Overview of Espacox
| Property | Description |
|---|---|
| Active ingredient | Toltrazuril |
| Form | Oral Suspension |
| Pharmacological class | Antiprotozoal / Coccidiocide |
| General purpose | Control and prevention of coccidiosis |
| Origin | Synthetic (Triazinone derivative) |
Espacox is a specialized veterinary medicinal product whose pharmacological activity is derived from its single active ingredient, Toltrazuril. This medicine is classified as an antiprotozoal agent, belonging specifically to the coccidiocide class. The key distinction of this substance is its definitive mode of action: unlike agents that merely slow parasite growth (coccidiostats), Toltrazuril acts to destroy the causative protozoa across all critical intracellular developmental stages. Toltrazuril is recognized for its efficacy against major coccidial species, making it a tool in preventative animal health programs. Consequently, the medicine is utilized as a standard for controlling this specific parasitic condition.
Composition, Origin, and Dosage Form
The core of Espacox is Toltrazuril at a strength of 50 mg/ml. As a derivative of triazinone, Toltrazuril is entirely of synthetic origin and is supplied as a ready-to-use oral suspension. The preparation is a single-agent product, relying exclusively on the activity of Toltrazuril without additional synergistic pharmacological substances. Being formulated as a suspension for oral use allows for specific calibration and reliable delivery of the necessary amount of the active compound to the digestive system, where the protozoal infection resides.
What is the General Purpose of this Coccidiocide?
The general purpose of Espacox is to control and prevent the clinical signs of coccidiosis by eliminating the responsible parasitic agents. The medicine’s coccidiocidal action specifically targets the parasite's metabolism and cell structure, thus terminating its reproductive cycle and preventing widespread cellular damage within the host's intestinal tract. The compound's efficacy involves targeting both the asexual and sexual phases of the Eimeria and Isospora protozoa. A typical use scenario involves administrating the product to neonatal animal groups, such as piglets, to prevent an outbreak of coccidiosis during a vulnerable stage of development. By clearing the parasitic load through this potent, definitive action, the medicine assists in maintaining the health and functional capacity of the animal's gut.
